Aerpio Pharmaceuticals Inc. - news published 33 - readings 522

BACK
Aerpio Pharmaceuticals Inc.

Aerpio Pharmaceuticals Inc.

Aadi Bioscience Appoints Emma Reeve to its Board of Directors (Form 8-K)

Aadi Bioscience Appoints Emma Reeve to its Board of Directors LOS ANGELES, Sept. 13, 2021 - Aadi Bioscience, Inc. ('Aadi') (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced the appointment of Emma Reeve to its Board of Directors as Audit Committee Ch ...

Continue reading
13.09.2021
Aerpio Pharmaceuticals Inc.

Aerpio Pharmaceuticals Inc.

Amendment No.1 to the Amended and Restated License Agreement between Abraxis BioScience, LLC and Aadi Bioscience, Inc (Form 8-K)

Amendment No.1 to the Amended and Restated License Agreement between Abraxis BioScience, LLC and Aadi Bioscience, Inc. On August 30, 2021, Aadi Subsidiary, Inc., a Delaware corporation (f/k/a AADi Bioscience, Inc., the ' Company Subsidiary '), a wholly-owned subsidiary of Aadi Bioscience, Inc., a Delaware corporation (f/k/a Aerpio Pharmaceuticals, Inc., the ' Company '), enter ...

Continue reading
03.09.2021